Serial sectioning further demonstrated that the SARS-CoV-2 spike protein and ACE2 were co-expressed in alveolar and bronchial epithelia of the COVID-19 cases (Fig. 2A and B), confirming that ACE2-expressing epithelial cells could be the target of SARS-CoV-2 in the lungs. This evidence concerns the gene ACE2 and COVID-19.